Browse > Article
http://dx.doi.org/10.5765/jkacap.2017.28.1.14

Pharmacologic Considerations for Youth with Posttraumatic Stress Disorder  

Keeshin, Brooks (Department of Pediatrics, University of Utah)
Strawn, Jeffrey R. (Department of Psychiatry, University of Cincinnati)
Publication Information
Journal of the Korean Academy of Child and Adolescent Psychiatry / v.28, no.1, 2017 , pp. 14-19 More about this Journal
Abstract
Children exposed to potentially traumatic events are at risk of developing posttraumatic stress disorder (PTSD). However, the subsequent developmental course of posttraumatic stress symptoms appears to vary considerably. In this regard, some PTSD symptoms resolve without significant interventions, while for many children and adolescents, they persist until the patient receives appropriate treatment specifically designed to address PTSD and other trauma related symptoms. Evidence-based psychotherapies represent the standard of care for children with PTSD and, while psychopharmacologic interventions are utilized for many youth with posttraumatic stress symptoms and PTSD, there is little data available to guide the use of these medications in this population. However, given the structural challenges involved in disseminating and delivering evidence-based psychotherapies in all settings, prescribing clinicians should be aware of the medications whose use in children with pediatric PTSD has been studied. Herein, we review the PTSD assessment modalities, as well as the use of pharmacologic interventions in PTSD, including antiadrenergic agents, selective serotonin reuptake inhibitors and other medications.
Keywords
Posttraumatic stress disorder; Treatment; Medication;
Citations & Related Records
연도 인용수 순위
  • Reference
1 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Arlington: American Psychiatric Publishing;2013.
2 Nemeroff CB, Weinberger D, Rutter M, MacMillan HL, Bryant RA, Wessely S, et al. DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions. BMC Med 2013;11:202.   DOI
3 Scheeringa MS. Developmental considerations for diagnosing PTSD and acute stress disorder in preschool and school-age children. Am J Psychiatry 2008;165:1237-1239.   DOI
4 Hafstad GS, Dyb G, Jensen TK, Steinberg AM, Pynoos RS. PTSD prevalence and symptom structure of DSM-5 criteria in adolescents and young adults surviving the 2011 shooting in Norway. J Affect Disord 2014;169:40-46.   DOI
5 Finkelhor D, Turner HA, Shattuck A, Hamby SL. Prevalence of childhood exposure to violence, crime, and abuse: results from the national survey of children's exposure to violence. JAMA Pediatr 2015;169:746-754.   DOI
6 Scheeringa MS, Wright MJ, Hunt JP, Zeanah CH. Factors affecting the diagnosis and prediction of PTSD symptomatology in children and adolescents. Am J Psychiatry 2006;163:644-651.   DOI
7 Daviss WB, Mooney D, Racusin R, Ford JD, Fleischer A, McHugo GJ. Predicting posttraumatic stress after hospitalization for pediatric injury. J Am Acad Child Adolesc Psychiatry 2000;39:576-583.   DOI
8 Stallard P, Velleman R, Baldwin S. Prospective study of post-traumatic stress disorder in children involved in road traffic accidents. BMJ 1998;317:1619-1623.   DOI
9 Keeshin BR, Strawn JR. Psychological and pharmacologic treatment of youth with posttraumatic stress disorder: an evidence-based review. Child Adolesc Psychiatr Clin N Am 2014;23:399-411, x.   DOI
10 Morina N, Koerssen R, Pollet TV. Interventions for children and adolescents with posttraumatic stress disorder: a meta-analysis of comparative outcome studies. Clin Psychol Rev 2016;47:41-54.   DOI
11 Cohen JA, Kelleher KJ, Mannarino AP. Identifying, treating, and referring traumatized children: the role of pediatric providers. Arch Pediatr Adolesc Med 2008;162:447-452.   DOI
12 Pine DS, Cohen JA. Trauma in children and adolescents: risk and treatment of psychiatric sequelae. Biol Psychiatry 2002;51:519-531.   DOI
13 Foa EB, McLean CP, Capaldi S, Rosenfield D. Prolonged exposure vs supportive counseling for sexual abuse-related PTSD in adolescent girls: a randomized clinical trial. JAMA 2013;310:2650-2657.   DOI
14 Sadowski CM, Friedrich WN. Psychometric properties of the trauma symptom checklist for children (TSCC) with psychiatrically hospitalized adolescents. Child Maltreat 2000;5:364-372.   DOI
15 Chung US. The Korean version of the trauma symptom checklist for children: psychometric properties and the connection to trauma among Korean children and adolescents. J Korean Med Sci 2014;29:837-845.   DOI
16 Strawn JR, Geracioti TD Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety 2008;25:260-271.   DOI
17 Keeshin BR, Strawn JR, Out D, Granger DA, Putnam FW. Elevated salivary alpha amylase in adolescent sexual abuse survivors with posttraumatic stress disorder symptoms. J Child Adolesc Psychopharmacol 2015;25:344-350.   DOI
18 Famularo R, Kinscherff R, Fenton T. Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. Am J Dis Child 1988;142:1244-1247.   DOI
19 Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry 2007;61:928-934.   DOI
20 Nugent NR, Christopher NC, Crow JP, Browne L, Ostrowski S, Delahanty DL. The efficacy of early propranolol administration at reducing PTSD symptoms in pediatric injury patients: a pilot study. J Trauma Stress 2010;23:282-287.
21 Raskind MA, Thompson C, Petrie EC, Dobie DJ, Rein RJ, Hoff DJ, et al. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry 2002;63:565-568.   DOI
22 Byers MG, Allison KM, Wendel CS, Lee JK. Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety. J Clin Psychopharmacol 2010;30:225-229.   DOI
23 Brkanac Z, Pastor JF, Storck M. Prazosin in PTSD. J Am Acad Child Adolesc Psychiatry 2003;42:384-385.   DOI
24 Oluwabusi OO, Sedky K, Bennett DS. Prazosin treatment of nightmares and sleep disturbances associated with posttraumatic stress disorder: two adolescent cases. J Child Adolesc Psychopharmacol 2012;22:399-402.   DOI
25 Strawn JR, Delbello MP, Geracioti TD. Prazosin treatment of an adolescent with posttraumatic stress disorder. J Child Adolesc Psychopharmacol 2009;19:599-600.   DOI
26 Strawn JR, Keeshin BR. Successful treatment of posttraumatic stress disorder with prazosin in a young child. Ann Pharmacother 2011;45:1590-1591.   DOI
27 De Bellis MD, Baum AS, Birmaher B, Ryan ND. Urinary catecholamine excretion in childhood overanxious and posttraumatic stress disorders. Ann N Y Acad Sci 1997;821:451-455.   DOI
28 Robb AS, Cueva JE, Sporn J, Yang R, Vanderburg DG. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol 2010;20:463-471.   DOI
29 Pervanidou P. Biology of post-traumatic stress disorder in childhood and adolescence. J Neuroendocrinol 2008;20:632-638.   DOI
30 Cohen JA, Mannarino AP, Perel JM, Staron V. A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. J Am Acad Child Adolesc Psychiatry 2007;46:811-819.   DOI
31 Stathis S, Martin G, McKenna JG. A preliminary case series on the use of quetiapine for posttraumatic stress disorder in juveniles within a youth detention center. J Clin Psychopharmacol 2005;25:539-544.   DOI
32 Meighen KG, Hines LA, Lagges AM. Risperidone treatment of preschool children with thermal burns and acute stress disorder. J Child Adolesc Psychopharmacol 2007;17:223-232.   DOI
33 Keeshin BR, Strawn JR. Risperidone treatment of an adolescent with severe posttraumatic stress disorder. Ann Pharmacother 2009;43:1374.
34 Looff D, Grimley P, Kuller F, Martin A, Shonfield L. Carbamazepine for PTSD. J Am Acad Child Adolesc Psychiatry 1995;34:703-704.   DOI
35 Steiner H, Saxena KS, Carrion V, Khanzode LA, Silverman M, Chang K. Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial. Child Psychiatry Hum Dev 2007;38:183-193.   DOI
36 Staller JA, Kunwar A, Simionescu M. Oxcarbazepine in the treatment of child psychiatric disorders: a retrospective chart review. J Child Adolesc Psychopharmacol 2005;15:964-969.   DOI
37 Cohen JA, Bukstein O, Walter H, Benson SR, Chrisman A, Farchione TR, et al. Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 2010;49:414-430.
38 Cohen JA, Mannarino AP, Iyengar S. Community treatment of posttraumatic stress disorder for children exposed to intimate partner violence: a randomized controlled trial. Arch Pediatr Adolesc Med 2011;165:16-21.
39 Berkowitz SJ, Stover CS, Marans SR. The Child and Family Traumatic Stress Intervention: secondary prevention for youth at risk of developing PTSD. J Child Psychol Psychiatry 2011;52:676-685.   DOI
40 Finkelhor D, Browne A. The traumatic impact of child sexual abuse: a conceptualization. Am J Orthopsychiatry 1985;55:530-541.   DOI
41 Horrigan JP, Barnhill LJ. The suppression of nightmares with guanfacine. J Clin Psychiatry 1996;57:371.
42 Connor DF, Ford JD, Arnsten AF, Greene CA. An update on posttraumatic stress disorder in children and adolescents. Clin Pediatr (Phila) 2015;54:517-528.   DOI
43 Deblinger E, Mannarino AP, Cohen JA, Runyon MK, Steer RA. Trauma-focused cognitive behavioral therapy for children: impact of the trauma narrative and treatment length. Depress Anxiety 2011;28:67-75.   DOI
44 Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 2009;48:884-893.   DOI
45 Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry 1996;35:1247-1249.   DOI
46 Porter DM, Bell CC. The use of clonidine in post-traumatic stress disorder. J Natl Med Assoc 1999;91:475-477.
47 Connor DF, Grasso DJ, Slivinsky MD, Pearson GS, Banga A. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol 2013;23:244-251.   DOI
48 Sallee FR, Lyne A, Wigal T, McGough JJ. Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009;19:215-226.   DOI
49 Strawn JR, Keeshin BR, DelBello MP, Geracioti TD Jr, Putnam FW. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. J Clin Psychiatry 2010;71:932-941.   DOI
50 Seedat S, Lockhat R, Kaminer D, Zungu-Dirwayi N, Stein DJ. An open trial of citalopram in adolescents with post-traumatic stress disorder. Int Clin Psychopharmacol 2001;16:21-25.   DOI
51 Seedat S, Stein DJ, Ziervogel C, Middleton T, Kaminer D, Emsley RA, et al. Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. J Child Adolesc Psychopharmacol 2002;12:37-46.   DOI